Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adriamycin & Docetaxel Signature Validation in Breast Cancer
NCT00669773Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Feb 2007
- Primary completion
- Feb 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, docetaxel in breast cancer, sponsored by National University Hospital. Status: unknown.
02
Drugs
doxorubicindocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00669773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669773.